NO910372L - Fremgangsmaate for fremstilling av heksahydropyrrolo(2,3-b)indolkarbamater-, urea-, amider og beslektede forbindelser og deres anvendelse som medikamenter. - Google Patents

Fremgangsmaate for fremstilling av heksahydropyrrolo(2,3-b)indolkarbamater-, urea-, amider og beslektede forbindelser og deres anvendelse som medikamenter.

Info

Publication number
NO910372L
NO910372L NO91910372A NO910372A NO910372L NO 910372 L NO910372 L NO 910372L NO 91910372 A NO91910372 A NO 91910372A NO 910372 A NO910372 A NO 910372A NO 910372 L NO910372 L NO 910372L
Authority
NO
Norway
Prior art keywords
indolcarbamater
medicines
amides
urea
procedure
Prior art date
Application number
NO91910372A
Other languages
English (en)
Other versions
NO910372D0 (no
NO175899C (no
NO175899B (no
Inventor
Gerald Joseph O'malley
Richard Charles Allen
John Irving White
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NO910372D0 publication Critical patent/NO910372D0/no
Publication of NO910372L publication Critical patent/NO910372L/no
Publication of NO175899B publication Critical patent/NO175899B/no
Publication of NO175899C publication Critical patent/NO175899C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO910372A 1990-02-01 1991-01-31 Analogifremgangsmåte for fremstilling av terapeutisk aktive heksahydropyrrolo(2,3-b)indol karbamater-, urea-, -amider og beslektede forbindelser NO175899C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/480,706 US4983616A (en) 1990-02-01 1990-02-01 Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds

Publications (4)

Publication Number Publication Date
NO910372D0 NO910372D0 (no) 1991-01-31
NO910372L true NO910372L (no) 1991-08-02
NO175899B NO175899B (no) 1994-09-19
NO175899C NO175899C (no) 1994-12-28

Family

ID=23909022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910372A NO175899C (no) 1990-02-01 1991-01-31 Analogifremgangsmåte for fremstilling av terapeutisk aktive heksahydropyrrolo(2,3-b)indol karbamater-, urea-, -amider og beslektede forbindelser

Country Status (17)

Country Link
US (1) US4983616A (no)
EP (1) EP0440145A1 (no)
JP (1) JP3042902B2 (no)
KR (1) KR0182296B1 (no)
AU (1) AU629094B2 (no)
CA (1) CA2035397C (no)
CZ (1) CZ281612B6 (no)
FI (1) FI94759C (no)
HU (1) HU217119B (no)
IE (1) IE910333A1 (no)
IL (1) IL97113A (no)
NO (1) NO175899C (no)
NZ (1) NZ236944A (no)
PL (1) PL288904A1 (no)
PT (1) PT96627A (no)
TW (1) TW206228B (no)
ZA (1) ZA91725B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US5187165A (en) * 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
AU634654B2 (en) * 1990-05-11 1993-02-25 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2934657A1 (de) * 1979-08-28 1981-03-12 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von thiochlorformiaten.
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
IT1225462B (it) * 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina
US4971992A (en) * 1989-03-27 1990-11-20 Hoechst-Roussel Pharmaceuticals Inc. Carbonate derivatives of eseroline
AU634654B2 (en) * 1990-05-11 1993-02-25 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments
AU634380B2 (en) * 1990-05-17 1993-02-18 Hoechst-Roussel Pharmaceuticals Incorporated Alpha-oxopyrrolo(2,3-b)indole acetic acids, esters, amides and related analogs, a process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
PL288904A1 (en) 1992-08-10
CZ281612B6 (cs) 1996-11-13
FI910448A (fi) 1991-08-02
AU629094B2 (en) 1992-09-24
CS9100215A2 (en) 1991-09-15
CA2035397C (en) 2001-10-23
ZA91725B (en) 1991-11-27
AU7011191A (en) 1991-08-08
IL97113A0 (en) 1992-03-29
JPH04330076A (ja) 1992-11-18
IE910333A1 (en) 1991-08-14
NO910372D0 (no) 1991-01-31
TW206228B (no) 1993-05-21
KR910021401A (ko) 1991-12-20
IL97113A (en) 1994-10-21
FI94759B (fi) 1995-07-14
HUT60499A (en) 1992-09-28
US4983616A (en) 1991-01-08
PT96627A (pt) 1991-10-15
NO175899C (no) 1994-12-28
HU910325D0 (en) 1991-08-28
NZ236944A (en) 1993-02-25
JP3042902B2 (ja) 2000-05-22
FI910448A0 (fi) 1991-01-30
HU217119B (hu) 1999-11-29
FI94759C (fi) 1995-10-25
EP0440145A1 (en) 1991-08-07
CA2035397A1 (en) 1991-08-02
NO175899B (no) 1994-09-19
KR0182296B1 (ko) 1999-05-01

Similar Documents

Publication Publication Date Title
NO904694D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO912672L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oligomerer.
NO903925D0 (no) Fremgangsmaate for fremstilling av 3-(1-substituert-4-piperazinyl)-1h-indazoler samt anvendelse som legemidler.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
ITRM920412A0 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO890269D0 (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
NO900697D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater.
NO900643D0 (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
NO910372L (no) Fremgangsmaate for fremstilling av heksahydropyrrolo(2,3-b)indolkarbamater-, urea-, amider og beslektede forbindelser og deres anvendelse som medikamenter.
NO903347L (no) 14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler.
NO890096L (no) Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter.
NO891046D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater.
NO921086L (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
NO894516D0 (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
NO893768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO911543D0 (no) Katalysatorsystem og fremgangsmaate for fremstilling av 1,2-diklorethan.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
IT8721540A0 (it) Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico.
NO901892L (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
NO900119L (no) Fremgangsmaate for fremstilling av 7-aryl- og heteroaryletere av desacetylforskolin, og deres anvendelse som medikamenter.
NO911810D0 (no) Pyrrolo(2,3-b)indol-ketoner og analoger, fremgangsmaate for fremstilling og anvendelse som medikamenter.
NO950118D0 (no) Fremgangsmåte for fremstilling av substituerte azoler, og anvendelse av midler som inneholder disse